(Q37324276)

19 August 2017

1 reference

26 October 2020

Oral cyclosporine A--the current picture of its liposomal and other delivery systems (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6275704&resulttype=core&format=json

13 May 2020

1 reference

26 October 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6275704&resulttype=core&format=json

13 May 2020

1

Aleksander Czogalla

1 reference

19005620

19 August 2017

publication date

12 November 2008

2 references

Cellular & Molecular Biology Letters

19 August 2017

26 October 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6275704&resulttype=core&format=json

13 May 2020

26 October 2020

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6275704&resulttype=core&format=json

13 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6275704&resulttype=core&format=json

13 May 2020

page(s)

139-152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6275704&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2478/s11658-008-0041-6

13 May 2020

exact match

0 references

cites work

Pharmacokinetic and pharmacodynamic evaluation of cyclosporin A O/W-emulsion in rats

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

The NMR structure of cyclosporin A bound to cyclophilin in aqueous solution

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Properties and stability of a liquid crystal form of cyclosporine-the first reported naturally occurring peptide that exists as a thermotropic liquid crystal

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Engineering polysaccharide-based polymeric micelles to enhance permeability of cyclosporin A across Caco-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Therapeutic drug monitoring of cyclosporine: 20 years of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Improved oral bioavailability of cyclosporin A in male Wistar rats. Comparison of a Solutol HS 15 containing self-dispersing formulation and a microsuspension

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Studies on the cyclosporin A loaded stearic acid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Experience with cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Interactions of cyclosporines with lipid membranes as studied by solid-state nuclear magnetic resonance spectroscopy and high-sensitivity titration calorimetry

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Disease, destination, dose and delivery aspects of ciclosporin: the state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Liposomes as cyclosporin A carriers: the influence of ordering of hydrocarbon chains of phosphatidylglycerol liposomes on the association with and topography of cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Generic cyclosporine formulations: more open questions than answers

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Crystal structure of human cyclophilin D in complex with its inhibitor, cyclosporin A at 0.96-A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Novel gels and their dispersions--oral drug delivery systems for ciclosporin

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Cyclosporin nanoparticulate lipospheres for oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Effects of cyclosporin A on model lipid membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Development of cyclosporin A-loaded hyaluronic microsphere with enhanced oral bioavailability.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

A polycaprolactone nanoparticle formulation of cyclosporin-A improves the prediction of area under the curve using a limited sampling strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Pharmacokinetic behavior of cyclosporin A in rabbits by oral administration of lecithin vesicle and Sandimmun Neoral

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Estimation of the increase in solubility of drugs as a function of bile salt concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Solubilization of cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Cyclosporine-loaded polycaprolactone nanoparticles: immunosuppression and nephrotoxicity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Incorporation of lipophilic drugs in sugar glasses by lyophilization using a mixture of water and tertiary butyl alcohol as solvent.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Structure refinement of cyclosporin A in chloroform by using RDCs measured in a stretched PDMS-gel

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Pharmacokinetic and pharmacodynamic evaluation of cyclosporin A O/W-emulsion and microsphere formulations in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Bioavailability of cyclosporin A dispersed in sodium lauryl sulfate-dextrin based solid microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Protective role of melatonin in cyclosporine A-induced oxidative stress in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Differentiation of absorption and first-pass gut and hepatic metabolism in humans: Studies with cyclosporine*

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A. Berlin, Germany, November 19, 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Cyclosporin A prodrugs: design, synthesis and biophysical properties

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Progress towards a molecular understanding of cyclosporin A-mediated immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Pharmacokinetics of two alternative dosage forms for cyclosporine: liposomes and intralipid

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Polyelectrolyte Nanoparticles with High Drug Loading Enhance the Oral Uptake of Hydrophobic Compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-008-0041-6

Interaction of cyclosporin A with dipalmitoylphosphatidylcholine

21 January 2018

1 reference

12 December 2020

Long-term studies on the stability and oral bioavailability of cyclosporine A nanoparticle colloid

1 reference

12 December 2020

Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation

1 reference

12 December 2020

Liposomal formulations of cyclosporin A: influence of lipid type and dose on pharmacokinetics

1 reference

12 December 2020

The increased efficacy and decreased nephrotoxicity of a cyclosporine liposome

1 reference

12 December 2020

Biosynthesis and mechanism of action of cyclosporins.

1 reference

12 December 2020

Enhancement of dissolution of cyclosporine A using solid dispersions with polyoxyethylene (40) stearate.

1 reference

12 December 2020

Impaired antioxidant defense system in the kidney tissues from rabbits treated with cyclosporine. Protective effects of vitamins E and C

1 reference

12 December 2020

Unusual solubility behaviour of cyclosporin A in aqueous media

1 reference

12 December 2020

Preparation, characterization and in vivo studies of proliposomes containing Cyclosporine A

1 reference

12 December 2020

Acutely impaired renal function during intravenous administration of cyclosporine A: a cremophore side-effect

1 reference

12 December 2020

Development and characterization of CyA-loaded poly(lactic acid)–poly(ethylene glycol)PEG micro- and nanoparticles. Comparison with conventional PLA particulate carriers

1 reference

12 December 2020

PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral

1 reference

12 December 2020

The effect of vehicle on the oral absorption of cyclosporin.

1 reference

12 December 2020

Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine

1 reference

12 December 2020

Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporation

1 reference

12 December 2020

Interactions of cyclosporin A with phospholipid membranes: effect of cholesterol

1 reference

12 December 2020

A water-soluble prodrug of cyclosporine A for ocular application: a stability study

1 reference

12 December 2020

A conformation of cyclosporin A in aqueous environment revealed by the X-ray structure of a cyclosporin-Fab complex

1 reference

12 December 2020

Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation

1 reference

12 December 2020

Stability of liposomes in vitro and their uptake by rat Peyer's patches following oral administration

1 reference

12 December 2020

Enhanced absorption of cyclosporin A by complexation with dimethyl-beta-cyclodextrin in bile duct-cannulated and -noncannulated rats

1 reference

12 December 2020

Effect of temperature on molecular structure of cyclosporin A.

1 reference

12 December 2020

Cyclosporine nephrotoxicity

1 reference

12 December 2020

Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration

1 reference

12 December 2020

Metabolism of cyclosporine by cytochromes P450 3A9 and 3A4

1 reference

12 December 2020

Solvent-dependent conformation and hydrogen-bonding capacity of cyclosporin A: evidence from partition coefficients and molecular dynamics simulations

1 reference

12 December 2020

Enhancing the bioavailability of cyclosporine a using solid dispersion containing polyoxyethylene (40) stearate

1 reference

12 December 2020

Crystal and molecular structure of an iodo-derivative of the cyclic undecapeptide cyclosporin A.

1 reference

12 December 2020

Interactions of cyclosporine and some derivatives with model membranes: binding and ion permeability changes

1 reference

12 December 2020

Liposomal cyclosporine. Characterization of drug incorporation and interbilayer exchange

1 reference

12 December 2020

10.2478/S11658-008-0041-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6275704&resulttype=core&format=json

Dimensions Publication ID

13 May 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6275704&resulttype=core&format=json

13 May 2020

19005620

1 reference